To further strengthen its executive leadership team, Eieling Technology officially announced that Dr Patrick Lau, former Deputy Executive Director of the Hong Kong Trade Development Council (HKTDC), has joined Eieling Technology as Chief Financial Officer.
Chief Financial Officer (CFO)
Dr Patrick Lau
Bachelor of Medicine and Laws (First Class Honours), Monash University, Melbourne
Dr Patrick Lau joined Eieling Technology as Chief Financial Officer in May 2026. He is a seasoned financing and M&A expert and a global strategist and dealmaker. From 2019 to March 2026, he served as Deputy Executive Director of the HKTDC, overseeing 51 global offices, promoting trade opportunities, and leading flagship initiatives including deal facilitation, T-box, GoGBA, and the Belt and Road. Prior to that, from 2000 to 2018, he worked at Baker McKenzie and Skadden, Arps, Slate, Meagher & Flom LLP, as well as investment banking at UBS and CCB International, where he rose to Managing Director, Head of M&A, and Assistant General Manager of Investment Banking, and also served as Investment Director at Khazanah Nasional Berhad, the sovereign wealth fund of Malaysia.
Mr Jia Xiaojia, CEO of Eieling Technology, commented: “Patrick brings extensive experience in financial investment and global trade promotion. As our business continues to expand and our international presence accelerates, we are confident that Patrick’s addition will complete the final piece of our puzzle!”
Patrick expressed his great honor to join Eieling Technology and his eagerness to work with the team to drive brand growth, solidly expand global markets, and help Eieling Technology achieve milestone breakthroughs in key business areas.
The addition of Dr Patrick Lau represents a further enhancement of Eieling Technology’s executive leadership team. His arrival brings significant support and elevation to the company in strategic planning, capital operations, and cross-border cooperation. Moreover, he will deeply integrate overseas business collaboration channels, enhance the company’s market influence and brand reputation, and provide strong and sustained momentum for Eieling Technology’s long-term development.
Eieling Technology is a key research commercialization spin-off from the Department of Biomedical Engineering at The Hong Kong Polytechnic University. Leveraging the PolyU AI Medical Ultrasound R&D team and its global commercialization team, the company is committed to providing healthcare providers worldwide with precise, reliable, and intelligent liver health diagnostic solutions.
As a global leader in AI-driven liver health, Eieling Technology currently offers a dual-product portfolio comprising the Liverscan® — Portable Liver Elastography Ultrasound Diagnostic System and the FattaLab® — Fatty Liver Diagnostic Device, covering both liver fat assessment and liver fibrosis evaluation. Eieling Technology is the only POCT manufacturer capable of providing a complete solution from fat quantification (FattaLab MAP) to fibrosis assessment (Liverscan LSM).
The company continues to deepen the application and penetration of AI technology, continuously upgrading product features to lower usage barriers and operational complexity. This addresses the challenges of scarce professional medical staff and lengthy training cycles at primary-level healthcare facilities, driving quality and efficiency improvements in grassroots medical services, and bringing liver health within easy reach. Eieling Technology is steadily advancing toward its goal of becoming a globally professional fatty liver health management platform service provider.
